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Abstract
Background: In many healthcare systems, people with severe joint disease wait months to years for joint replacement
surgery. There are little empirical data on the health consequences of this delay and it is unclear whether people with
substantial morbidity at entry to the waiting list continue to deteriorate further while awaiting surgery. This study
investigated changes in Health-Related Quality of Life (HRQoL), health status and psychological distress among people
waiting for total hip (THR) and knee replacement (TKR) surgery at a major metropolitan Australian public hospital.
Methods: 134 patients completed questionnaires including the Assessment of Quality of Life (AQoL) instrument,
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Kessler Psychological Distress Scale
after entering an orthopaedic waiting list (baseline) and before surgery (preadmission). To quantify potential
decline in wellbeing, we calculated the proportion of people experiencing clinically important deterioration using
published guidelines and compared HRQoL and psychological distress outcomes with population norms.
Results: Most participants (69%) waited ≥6 months for surgery (median 286 days, IQR 169-375 days). Despite poor
physical and psychological wellbeing at baseline, there was an overall deterioration in HRQoL during the waiting period
(mean AQoL change -0.04, 95%CI -0.08 to -0.01), with 53% of participants experiencing decline in HRQoL (≥0.04 AQoL
units). HRQoL prior to surgery remained substantially lower than Australian population norms (mean sample AQoL 0.37,
95%CI 0.33 to 0.42 vs mean population AQoL 0.83, 95%CI 0.82 to 0.84). Twenty-five per cent of participants showed
decline in health status (≥9.6 WOMAC units) over the waiting period and prevalence of high psychological distress
remained high at preadmission (RR 3.5, 95%CI 2.8 to 4.5). Most participants considered their pain (84%), fatigue (76%),
quality of life (73%) and confidence in managing their health (55%) had worsened while waiting for surgery.
Conclusions: Despite substantial initial morbidity, over half of the participants awaiting joint replacement
experienced deterioration in HRQoL during the waiting period. These data provide much-needed evidence to
guide health professionals and policymakers in the design of care pathways and resource allocation for people
who require joint replacement surgery.
Background
As in many developed countries, demand for joint repla-
cement surgery in Australia has grown rapidly. The
number of joint replacements performed has doubled
over the past 12 years [1] and further increases are
expected in light of the ageing population and increasing
risk factors for osteoarthritis [2]. A mismatch between
demand for surgery and service provision has resulted
in lengthy waiting lists for primary total hip (THR) and
knee replacement (TKR) in the Australian public hospi-
tal system [3], representing a major public health and
political issue unlikely to abate in the near future. Simi-
lar situations exist in other countries including Canada
[4] and the United Kingdom (UK) [5].
Our earlier research showed that people entering an
Australian orthopaedic waiting list for joint replacement
had severely compromised Health-Related Quality of
Life (HRQoL) and higher levels of psychological distress
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recently, poor HRQoL has also been reported in a
cross-sectional study of Canadian patients entering a
waiting list for TKR [7]. However, it is unclear whether
people with substantial morbidity at entry to the waiting
list continue to deteriorate further while awaiting sur-
gery. Further decline could potentially result from
increasing joint disease severity over time and the asso-
ciated difficulty in maintaining activity levels, employ-
ment and family and community roles. Although a
range of studies have prospectively evaluated changes in
the health status of people waiting for joint replacement
[8-13], results have been conflicting and average waiting
times relatively short (range 2-6 months). Hoogeboom
et al [14] were unable to perform a meta-analysis due to
the heterogeneity of studies in this field but their pub-
lished ‘qualitative data analysis’ concluded that neither
pain (for people awaiting THR or TKR) nor function
(for people awaiting THR) deteriorated when waiting
less than 6 months for surgery. The effect of waiting
longer than 6 months could not be determined. Indeed,
little research has been conducted into the impact of
longer waiting times for joint replacement on patient
wellbeing. A Swedish study found that people waiting,
on average, 8 months for THR experienced significant
d e t e r i o r a t i o ni nH R Q o La l t h o u g hc h a n g e si np a i na n d
function over the waiting period are unclear as these
analyses were not specifically reported [15]. Research
from the UK involving people waiting for THR or TKR
revealed small fluctuations in pain and physical function
over the waiting period although less than 50% of parti-
cipants were available for follow-up after 6 months of
waiting and only 23% were available at the 9-month
time point [16]. Most recently, Desmeules et al [13]
reported deterioration in pain and physical function
among people waiting more than 9 months for TKR in
Canada; however, as data were only reported for 3 of
the 8 Medical Outcomes Study Short Form Health Sur-
vey (SF-36) dimensions it is difficult to evaluate change
in overall HRQoL.
As pre-operative wellbeing is an important predictor
of joint replacement outcomes [9,17,18], knowledge of
changes in health status represents valuable information
for patients, clinicians and health policy makers and
offers potential avenues for future interventions. To
inform clinical practice and health policy, this study
investigated changes in key indicators of wellbeing
(HRQoL, health status, psychological distress and self-
perceived change) among people awaiting THR or TKR.
Methods
Participants
This study comprised a cohort of patients awaiting joint
replacement at the Royal Melbourne Hospital, Victoria,
Australia (a large metropolitan public teaching hospital).
Patients entered the orthopaedic waiting list following
referral from a general practitioner and consultation
with an orthopaedic surgeon. The study recruitment
procedures have been described previously [6]; all
patients on the waiting list for unilateral primary THR
or TKR as of December 2002 were contacted about the
study. Furthermore, from December 2002 to June 2005,
all patients sequentially added to the waiting list were
contacted within one week. No sample size target was
specified ap r i o r i . Patients were eligible to participate if
aged over 18 years, awaiting unilateral primary THR or
TKR and fluent in English. Exclusion criteria included
overt evidence of cognitive dysfunction, surgery sched-
uled within 30 days or severe medical illness precluding
participation. The study was approved by the Melbourne
Health Human Research Ethics Committee. All data col-
lection was undertaken from 2002 to 2005.
Eligible patients who provided verbal consent were
mailed a consent form and baseline questionnaire (base-
line assessment). A preadmission questionnaire was
mailed once a preadmission clinic appointment had
been scheduled, generally 2-6 weeks before surgery (pre-
admission assessment). Missing data were followed-up
by telephone or mail, where possible. Baseline data were
collected from 328 participants; however, similar to pre-
vious research in this field [12], a considerable number
of participants were not available for follow-up. This
was predominantly due to participants having not been
scheduled for surgery by the end of the 2.5 year data
collection period (Figure 1). This paper reports 134 par-
ticipants who completed baseline and preadmission
assessments.
Questionnaires
HRQoL was assessed using the 12-item generic Assess-
ment of Quality of Life (AQoL) instrument [19]. The
AQoL has good psychometric properties and is more
responsive than other widely-used generic scales, includ-
ing the SF-36 [20,21]. It produces a utility value ranging
from -0.04 (worst HRQoL) to 1.00 (full HRQoL).
The Western Ontario and McMaster Universities
Osteoarthritis (WOMAC) Index is an osteoarthritis-specific
health status instrument; its validity, reliability and respon-
siveness have been extensively demonstrated [22]. The
WOMAC consists of 24 questions and produces a total
score which was transformed to a 0 (best health state) to
100 (worst health state) scale.
The Kessler Psychological Distress Scale (K10) is used
in Australian population health surveys and the World
Health Organisation World Mental Health Survey [23].
The K10 consists of 10 questions and produces a score
ranging from 10 (lowest psychological distress) to 50
(highest psychological distress). High K10 scores are
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sion and anxiety [24].
Demographic information including education, marital
status and employment status and past medical history
were collected at baseline. Additional information
extracted from patient records included date of birth,
date of entry to the waiting list, preadmission clinic and
surgery dates and surgery type. At preadmission, partici-
pants were also asked to rate their self-perceived change
(if any) in pain, fatigue, overall quality of life, overall
health and confidence in managing their health since
entering the waiting list. Self-perceived change was
assessed on a 7-point scale ranging from ‘ag r e a td e a l
worse’ to ‘a great deal better’.
Statistical analyses
Analyses were undertaken using Statistical Package for
the Social Sciences (SPSS) Version 14.0. Questionnaire
scores were calculated according to published algo-
rithms [24-26]. Missing values were imputed using the
mean values of the remaining items, provided that a suf-
ficient proportion of remaining items were available, as
specified by the scoring guidelines for each measure.
Mann Whitney, chi square and unpaired t-tests were
used to compare demographic and baseline data from
participants who completed baseline and preadmission
questionnaires with those who provided baseline data
only. Changes in HRQoL, health status and psychologi-
cal distress from baseline to preadmission were exam-
ined using paired t-tests. Effect sizes were used to
estimate the magnitude of overall change (calculated by
dividing the change score for each measure by the base-
line standard deviation) [27]. Self-perceived change data
were analysed descriptively.
The proportion of people who experienced clinically
important change in HRQoL and health status was calcu-
lated according to published data for the AQoL and
WOMAC instruments. Clinically important deterioration
in HRQoL was defined as a decrease of ≥0.04 AQoL
units and improvement as an increase of ≥0.04 AQoL
units [28]. Clinically important deterioration in health
status was defined as an increase of ≥9.6 WOMAC units
and improvement as a decrease of ≥8.2 WOMAC units
[29]. The relationship between baseline status and cate-
gory of clinically important change for the AQoL and
WOMAC measures was investigated using analysis of
covariance, with adjustment for age and gender. Separate
analyses for THR and TKR were not undertaken due to
the limited sample size. The potential contribution of
regression to the mean (RTM) was evaluated by repeating
Entered orthopaedic waiting list
877
Able to be contacted
811
Ineligible
288 language difficulties
33 not waiting for primary THR/TKR 
at study hospital
15 severe illness precluding 
participation
5 surgery <30 days
5 did not meet age requirements
3 diagnosis known to be other than 
arthritis
2 overseas
1 cognitive impairment 
352
Eligible
459
Declined to participate
73
Did not return baseline 
questionnaire
58
Returned baseline questionnaire
328
115 remained on waiting list
15 recruited into other studies
15 received surgery elsewhere
8 no longer on waiting list
2 revoked consent
1 died
156
Returned preadmission 
questionnaire and available 
for analysis
134
Allocated preadmission and/or 
surgery dates
172
Unable to contact
66
Did not return 
preadmission 
questionnaire
18
Missed follow-up due 
to staff absence or 
database setup
20
Figure 1 Participant numbers.
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scores (the top 5% and the bottom 5% of baseline scores
for each measure). RTM is a statistical phenomenon
which may occur with repeated measurements, where
extreme measures obtained at the first time point are
likely to be closer to the sample mean on subsequent
testing due to random error [30]. This is particularly rele-
vant for the present study which involves participants
with very poor wellbeing at baseline (as only those with
severe joint disease enter the orthopaedic waiting list).
Although a definitive test is not available, the exclusion
of extreme scores was used as scores at the upper and
lower limits of a scale are theoretically most susceptible
to RTM [30].
Baseline and preadmission K10 scores were cate-
gorised into levels of psychological distress according to
published definitions [31] and compared with data from
the Victorian Population Health Survey [32]. Relative
risk (RR) for presence of high/very high psychological
distress (K10 ≥22) compared with population levels was
calculated using Confidence Interval Analysis software
(Version 2.0.0) [33].
Results
Comparison of demographic and baseline data
Table 1 shows that participants who completed baseline
and preadmission questionnaires (n = 134) were similar
to those who completed a baseline questionnaire only (n
= 194) across a range of demographic and baseline char-
acteristics. This suggests that the sample can be consid-
ered broadly representative of our overall cohort at
baseline.
Demographics and waiting times
Demographic data for the study sample are presented in
Table 1. The median (IQR) time from entry to the wait-
ing list to surgery was 286 (169-375) days (range 43-
1069 days). Twenty-five per cent of participants waited
less than 6 months for surgery (n = 33), 43% (n = 57)
waited 6-12 months and 26% (n = 35) waited more than
12 months. Waiting time data were not available for 9
participants (7%). The median (IQR) time between base-
line and preadmission questionnaires was 165 (84-268)
days, with preadmission questionnaires completed, on
average, 1 month before surgery (median 30 days, IQR
18-49 days).
Seventy-eight per cent of participants (n = 104) had
self-reported osteoarthritis and 18% (n = 24) reported
rheumatoid arthritis. Other concurrent musculoskeletal
conditions included back pain (n = 59, 44%), osteoporosis
(n = 18, 13%), gout (n = 9, 7%) and fibromyalgia (n =1 ,
<1%). Twenty per cent (n = 27) had received a previous
joint replacement. Using a checklist of 6 common condi-
tions, 40% of participants (n = 53) had hypertension, 13%
(n =1 8 )h a dd i a b e t e s ,1 3 %( n = 17) had coronary artery
disease, 12% (n = 16) had asthma, 11% (n = 15) had anxi-
ety or depression and 4% (n = 5) had cancer.
Changes in wellbeing from baseline to preadmission
Table 2 shows that there was a clinically important
decline in HRQoL from baseline to preadmission.
Although the effect size for deterioration in HRQoL was
small, from a clinical perspective, this represents 22% of
the magnitude of change in HRQoL 3 months after THR
or TKR (effect size 0.86) [34]. Preadmission HRQoL for
the combined sample (THR and TKR) was extremely
poor when compared with Australian population norms
(mean preadmission AQoL score 0.37, 95%CI 0.33 to
0.42 versus mean population AQoL score 0.83, 95%CI
0.82 to 0.84) [28]. Separate analyses by operation type
(THR or TKR) revealed that participants awaiting THR
experienced a decline in HRQoL (Table 2). The magni-
tude of this effect size represents almost one-third of the
change in HRQoL from joint replacement [34]. On aver-
age, participants awaiting TKR experienced little change
in HRQoL (Table 2).
While the combined sample demonstrated poor health
status at baseline, there was little overall change in
WOMAC score over the waiting period. Similarly, there
was minimal overall change in psychological distress
from baseline to preadmission. Separate analysis of THR
and TKR data produced similar results (Table 2).
Missing item responses were infrequent for the AQoL
(2% of items at baseline; 1% of items at preadmission),
WOMAC (3% at baseline; 4% at preadmission) and K10
(0% at baseline; <1% at preadmission) instruments.
Proportion of participants who experienced clinically
important change
Table 3 shows the variability in wellbeing over the wait-
ing period. A substantial proportion of the combined
sample (53%) experienced a clinically important decline
in HRQoL while awaiting surgery (56% for THR; 50%
for TKR). Conversely, 29% experienced clinically impor-
tant improvement in HRQoL (25% for THR; 33% for
TKR) while 18% had no change (19% for THR; 17% for
TKR).
Twenty-five per cent of participants had a clinically
important deterioration in health status (26% for THR;
24% for TKR), 24% experienced clinically important
improvement (23% for THR; 24% for TKR) and 51%
had no change in health status (51% for THR; 52% for
TKR).
Sensitivity analysis
After adjusting for age and gender, participants who
experienced a clinically important decline in HRQoL
had the highest HRQoL at baseline, while those who
Ackerman et al. BMC Musculoskeletal Disorders 2011, 12:108
http://www.biomedcentral.com/1471-2474/12/108
Page 4 of 9had a clinically important improvement in HRQoL
reported the lowest HRQoL at baseline (mean (SD)
baseline AQoL score 0.47 (0.19) versus 0.35 (0.22); F =
3.54, p = 0.03). As a similar pattern was seen for health
status (mean (SD) baseline WOMAC score 46.9 (16.5)
versus 70.3 (19.5); F = 14.32, p < 0.01), it is possible that
these findings may be partly related to RTM. After
excluding extreme baseline scores and repeating the
Table 1 Comparison of demographic and baseline characteristics
Characteristic Baseline and preadmission data
(n = 134*)
Baseline data only
(n = 194*)
p
Age in years: median (IQR) 67 (61-75) 68 (61-75) 0.87
†
Female: number (%) 79 (59) 108 (56) 0.56
‡
Waiting for TKR: number (%) 69 (52) 110 (57) 0.35
‡
Married or living with partner: number (%) 85 (64) 114 (59) 0.35
‡
Highest educational level completed: number (%) 0.50
‡
Primary school or less 41 (31) 52 (27)
Years 7-10 51 (39) 77 (40)
Years 11-12 25 (19) 31 (16)
Trade/technical/university 15 (11) 32 (17)
Employment status: number (%) 0.25
‡
Retired/receiving aged pension 92 (70) 141 (73)
Not in paid work 28 (21) 29 (15)
Paid work 11 (8) 23 (12)
Income: number (%) 0.52
‡
<$AUD 10,000 17 (18) 37 (24)
$AUD 10,000 - 19,999 46 (49) 68 (44)
$AUD 20,000 and over 31 (33) 48 (31)
Number of co-morbidities: median (IQR) 1 (0-2) 1 (0-2) 0.36
†
Baseline AQoL score: mean (SD) 0.42 (0.23) 0.39 (0.26) 0.35
#
Baseline WOMAC score: mean (SD) 59.8 (18.4) 58.8 (18.5) 0.64
#
Baseline K10 score: median (IQR) 18.0 (14.0-25.0) 19.0 (14.0-27.0) 0.52
†
*Numbers for each characteristic may not total 134 or 194, respectively, due to missing responses.
†Mann Whitney test.
‡Chi square test.
#Unpaired t-test.
Table 2 Change in Health-Related Quality of Life, health status and psychological distress
Baseline Preadmission Change Effect size
† p**
Construct
‡ n* Mean SD Mean SD Mean
# 95% CI
Health-Related Quality of Life (AQoL)
Overall sample 127 0.42 0.22 0.37 0.25 -0.04 -0.08 to -0.01 -0.19 0.02
Total hip replacement 63 0.42 0.23 0.36 0.24 -0.06 -0.11 to -0.02 -0.27 0.01
Total knee replacement 64 0.41 0.22 0.39 0.26 -0.02 -0.08 to 0.03 -0.10 0.39
Health status (WOMAC)
Overall sample 119 59.7 18.6 61.3 18.0 1.5 -1.1 to 4.2 -0.08 0.26
Total hip replacement 61 60.5 20.5 62.1 18.6 1.7 -1.9 to 5.2 -0.08 0.35
Total knee replacement 58 59.0 16.5 60.3 17.4 1.4 -2.7 to 5.4 -0.08 0.50
Psychological distress (K10)
Overall sample 132 20.2 7.7 20.7 8.0 0.5 -0.4 to 1.4 -0.07 0.25
Total hip replacement 65 19.7 7.9 20.2 8.0 0.5 -0.9 to 1.9 -0.06 0.50
Total knee replacement 67 20.7 7.6 21.3 8.0 0.5 -0.6 to 1.7 -0.07 0.33
‡AQoL range: -0.04 (worst HRQoL) to 1.00 (full HRQoL); WOMAC range: 0 (best health state) to 100 (worst health state); K10 range: 10 (lowest psychological
distress) to 50 (highest psychological distress).
*Number of participants with complete baseline and preadmission data for each measure; does not total 134 due to missing data.
#Negative change score indicates deterioration for AQoL; positive change score indicates deterioration for WOMAC and K10.
†Negative effect size indicates deterioration.
**Paired t-test.
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admission change was found to be the same or larger
than for the original analyses (effect size -0.26 for
AQoL, -0.14 for WOMAC and -0.07 for K10). This sug-
gests that the effect of RTM was likely to be minimal
and that it may have (to a small degree) masked the
true magnitude of change during the waiting period.
Additionally, as the sample reported, on average, very
poor HRQoL at baseline, the net effect of RTM should
have produced an overall trend towards improvement in
HRQoL; in contrast, HRQoL deteriorated significantly
from baseline to preadmission.
Risk of psychological distress
For the combined sample, high or very high psychologi-
cal distress remained more prevalent compared with the
general population at preadmission (RR 3.5, 95%CI 2.8
to 4.5). Relative risk (95%CI) was 3.4 (2.4 to 4.8) for par-
ticipants awaiting THR and 3.7 (2.7 to 5.1) for partici-
pants awaiting TKR.
Self-perceived change in wellbeing
Table 4 shows that most participants perceived that
their pain, fatigue, overall quality of life, overall health
and confidence in managing their health had worsened
since entering the waiting list. At the extreme end of
the scale, over one-third (36%) considered their pain
was ‘a great deal worse’; while 17% reported their overall
quality of life was ‘a great deal worse’. Separate analysis
by operation type (THR or TKR) produced similar
results, although a greater proportion of participants
awaiting THR considered their overall quality of life was
‘a great deal worse’ (24% versus 10% for TKR).
Discussion
This study demonstrates that despite substantial initial
morbidity, 53% of people awaiting joint replacement
experienced deterioration in HRQoL over the waiting
period. Life quality before surgery was markedly lower
than Australian population norms [28] and the preva-
lence of high psychological distress remained higher
than for the general population. In general, participants
perceived their pain, fatigue, quality of life, overall health
and confidence in managing their health had worsened
while waiting. These findings are concerning given that
pre-operative wellbeing is a strong predictor of outcome
after joint replacement surgery [18,35,36].
It is unclear why people awaiting THR reported, on
average, greater deteriora t i o ni nH R Q o Lt h a np e o p l e
Table 3 Proportion of participants reporting clinically important change
Construct Category
Decline* n (%) No change n (%) Improvement
† n (%)
Health-Related Quality of Life (AQoL)
Overall sample 67 (53) 23 (18) 37 (29)
Total hip replacement 35 (56) 12 (19) 16 (25)
Total knee replacement 32 (50) 11 (17) 21 (33)
Health status (WOMAC Index)
Overall sample 30 (25) 61 (51) 28 (24)
Total hip replacement 16 (26) 31 (51) 14 (23)
Total knee replacement 14 (24) 30 (52) 14 (24)
*Decrease of ≥0.04 units for AQoL instrument; increase of ≥9.6 units for WOMAC Index.
†Increase of ≥0.04 units for AQoL; decrease of ≥8.2 units for WOMAC Index.
Table 4 Self-perceived change in wellbeing
Construct Worse* No change Better
#
n %
† n %
† n %
†
Pain
Overall sample 112 85 15 11 5 4
Total hip replacement 59 92 5 8 0 0
Total knee replacement 53 78 10 15 5 7
Fatigue
Overall sample 100 76 27 21 5 4
Total hip replacement 49 77 14 22 1 2
Total knee replacement 51 75 13 19 4 6
Overall quality of life
Overall sample 96 73 30 23 6 5
Total hip replacement 48 76 14 22 1 2
Total knee replacement 48 70 16 23 5 7
Overall health
Overall sample 72 55 49 37 10 8
Total hip replacement 34 54 26 41 3 5
Total knee replacement 38 56 23 34 7 10
Confidence in managing one’s health
Overall sample 74 56 46 35 13 10
Total hip replacement 37 58 20 31 7 11
Total knee replacement 37 54 26 38 6 9
*Combines ‘A great deal worse’, ‘Moderately worse’ and ‘A little worse’
categories.
#Combines ‘A little better’, ‘Moderately better’ and ‘A great deal better’
categories.
†May not total 100% due to rounding.
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self-perceived change data. Possible contributing factors
such as age and number of co-morbidities were similar
for both groups (data not shown) and people awaiting
TKR had a longer median waiting time (309 days for
TKR versus 243 days for THR). Deterioration in HRQoL
has also been reported in people awaiting THR in the
Netherlands [9] and Sweden [15] using a different
HRQoL utility measure, the EQ-5D. Other studies have
investigated HRQoL in people awaiting joint replace-
ment but cannot be directly compared with our find-
ings. In one, utility scores for the EQ-5D were not
reported and as deterioration was observed in only one
of five EQ-5D dimensions [10], it is unlikely that this
would result in HRQoL decline. Hirvonen et al [11] did
not observe a change in HRQoL (assessed using the
15D utility instrument) among people awaiting THR or
TKR in Finland, although most participants (71%)
waited 3 months or less, which is considerably shorter
than in Australia, Canada and the United Kingdom.
Using the SF-36 instrument, McHugh et al [16] found
l i t t l ec h a n g ei nH R Q o La m o n gp e o p l ew a i t i n gf o rT H R
and TKR, although these data were not analysed sepa-
rately. Most recently, Desmeules et al [13] also assessed
HRQoL in people waiting for TKR but only reported
change data for 3 of the SF-36 dimensions.
The finding of significant deterioration in HRQoL
without a corresponding change in health status or psy-
chological distress scores does appear to be counter-
intuitive. However, for both the WOMAC and K10
measures, there was an overall trend towards deteriora-
tion from baseline to preadmission although the magni-
tude of change was small and un l i k e l yt ob ec l i n i c a l l y
relevant (effect sizes -0.08 and -0.07, respectively). As a
g e n e r i cm e a s u r eo fH R Q o L ,t h eA Q o Li n s t r u m e n tp r o -
vides different informationt ot h a to b t a i n e df r o mt h e
other instruments and this may partly explain our find-
ings. For example, the AQoL incorporates a number of
constructs relating to physical functioning that are not
assessed by the WOMAC but that may be impacted by
severe joint disease, such as the level of assistance
required for personal care and household tasks. Simi-
larly, it also covers areas relating to psychosocial well-
being which are not included in the K10, such as
relationships with others (as affected by health), social
isolation, the capacity to undertake one’s role within the
family and the ability to sleep. Although the impact of
longer waiting times has been unclear [14], several stu-
dies have reported deterioration in WOMAC pain and/
or physical function subscale scores among people wait-
ing for joint replacement. While these changes have
been statistically significant, the mean changes in
WOMAC scores have tended to be small [9,10,13,16].
In contrast, an earlier Canadian study found no change
in WOMAC scores over the waiting period [8]. Interest-
ingly, the present cohort had worse baseline WOMAC
pain and physical function subscale scores (data not
shown) than reported for other cohorts [8,10,12,13]
indicating greater initial morbidity. Previous studies
investigating psychological wellbeing have produced
conflicting results and are not directly comparable with
the present study due to the different measures used.
Kelly et al [8] reported improvements in SF-36 mental
health and role emotional dimension scores for people
awaiting TKR, while those awaiting THR did not
change. In contrast, another study involving people wait-
ing for THR found a small decline in SF-36 mental
health scores [9]. More recently, McHugh et al [16]
reported minimal deterioration in SF-36 mental health
scores after 6 months of waiting for joint replacement,
while role emotional scores improved.
It is possible that health status and psychological dis-
tress fluctuated over the waiting period, similar to the
fluctuations in pain and physical function previously
reported for this patient group [16]; however, our meth-
odology allowed us to evaluate overall change only. Ide-
ally, regular assessments (eg. 6 monthly) could be used
to determine rate of change. Also, the present study was
only conducted at one public hospital, although baseline
HRQoL was comparable to that of people awaiting joint
replacement at other large public hospitals in the state
of Victoria (range of mean AQoL scores from five Vic-
torian public hospitals = 0.33 to 0.39, Osborne et al,
unpublished data). Another limitation reflecting the ‘real
world setting’ of this study is the considerable number
of participants who were not scheduled for surgery by
the end of the 2.5 year data collection period (at the
time of this study there was no standardised process at
the study hospital for determining surgical priority and/
or exit from the waiting list). However, comparison of
demographic and baseline data indicated that the study
sample was representative of our overall cohort.
Our use of transition questions to explore self-per-
ceived change across a range of constructs was a novel
approach in this field; however, these results should be
interpreted cautiously as they rely on participant recall
[37] and may be subject to bias including response shift
[38]. It is unlikely; however, that participants reported
worsening to receive earlier surgery as preadmission
questionnaires were only administered once surgery was
imminent. Floor or ceiling effects are also unlikely to
have impacted on the findings as few participants
reported minimum or maximum possible scores for any
of the outcome measures (data not shown). It should be
acknowledged that the present data are self-reported
and further research involving performance-based mea-
sures would provide additional information to improve
our understanding of changes in physical function while
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Page 7 of 9waiting for surgery. In this study, participants were
asked to report their use of medications at each assess-
ment; however, given the variability in the type (pre-
scribed, over-the-counter and complementary) and
dosages of medications reported, these data were not
included in the analyses. Additionally, participants were
asked to report the number of visits to a general practi-
tioner, orthopaedic surgeon, rheumatologist or phy-
siotherapist at baseline and preadmission; on average,
there were few visits to any of these health professionals
at either point (data not shown). However, it should be
acknowledged that some participants did use medica-
tions (such as paracetamol and non-steroidal anti-
inflammatory drugs) and other conservative therapies
and that the negative effects of waiting for surgery
might be worse in the absence of any therapy. Finally,
t h er e s u l t sa r ea l s ol i k e l yt or e p r e s e n tac o n s e r v a t i v e
estimate of deterioration given that only the distal por-
tion of the entire waiting period was assessed (for exam-
ple, time spent waiting for an initial consultation with
an orthopaedic surgeon was not included) and pread-
mission clinic dates were used to approximate the end
of the waiting period.
Despite these limitations, this study has informed
aspects of local health policy and patient care. In the
state of Victoria, Australia, the Victorian Government
has implemented a program to improve the manage-
ment and prioritisation of people referred to orthopae-
dic waiting lists [39]. This program involved the
development of a new surgical prioritisation tool (the
Multi-Attribute Prioritisation Tool) [40] and service
delivery model (the OA Hip and Knee Service) which
are now being introduced into major public hospitals in
several Australian states. As part of the new system,
musculoskeletal co-ordinators periodically assess people
awaiting joint replacement to identify deterioration (or
improvement) and initiate appropriate services or fast-
track surgery as required. Routine, effective prioritisation
together with clinical assessment also ensures more
timely and equitable access to surgery for those with the
greatest need.
Conclusions
This research has revealed that more than half of those
waiting for joint replacement experienced substantial
deterioration in HRQoL. While there was little overall
change in health status and psychological distress over
the waiting period, most people perceived that other
aspects of their wellbeing including pain, fatigue and
confidence in managing their health had worsened while
waiting. By highlighting the severe morbidity of this
patient group and the need for periodic monitoring, this
research has provided much-needed evidence to guide
health professionals and policymakers in the develop-
ment of care pathways and resource allocation.
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